[Chronic hepatitis C in hemodialysis patients].
Tanaka
Hiroto
H
Third Department of Internal Medicine, Wakayama Medical University.
Ueda
Hiroki
H
Ichinose
Masakazu
M
Miyano
Motoshige
M
D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000453:epidemiology / Q000209:etiology; D018450:Disease Progression; D005355:Fibrosis; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology / Q000635:transmission*; D006801:Humans; D007372:Interferons / Q000009:adverse effects / Q000627:therapeutic use; D008099:Liver / Q000473:pathology; D008113:Liver Neoplasms / Q000453:epidemiology / Q000209:etiology; D006435:Renal Dialysis / Q000009:adverse effects*
D000998:Antiviral Agents; D007372:Interferons